AUTHORS
Shannon Phillips, PhD, RN, Alyssa Schlenz, PhD2, Jeffrey Lebensburger, DO3, Christina Abrams, MD4, Ofelia A. Alvarez, MD5, Beng Fuh, MD, PhD6, Najibah Galadanci, PhD, MBBS, MPH7, Matthew Hayat, PhD8, Margaret Prentice, MBA9, Chelsea Rivenbark10, Julie Kanter, MD11
AFFILIATIONS
1 Medical University of South Carolina, Charleston, South Carolina, United States
2 University of Colorado Anschutz School of Medicine, Aurora, Colorado, United States
3 University of Alabama at Birmingham, Birmingham, Alabama, United States
4 Medical University of South Carolina, Charleston, South Carolina, United States
5 University of Miami, Miami, Florida, United States
6 East Carolina University, Greensville, North Carolina, United States
7 University of Alabama at Birmingham, Birmingham, Alabama, United States
8 Medical University of South Carolina, Charleston, South Carolina, United States
9 Medical University of South Carolina, Charleston, South Carolina, United States
10 East Carolina University, Greensville, North Carolina, United States
11 University of Alabama at Birmingham, Birmingham, Alabama, United States
ABSTRACT
Background and Significance: Effective self-management skills and behavior development are critical for adolescents and young adults (AYA) with sickle cell disease (SCD) preparing to transition to independent management and adult care. Rates of complications, acute care utilization, and death rise dramatically in this population following transfer to adult care. To support self-management behavior development and mitigate negative outcomes, we developed a multi-component, self-management intervention delivered via an mHealth application (app; Voice Crisis Alert V2). The intervention’s intent is a broadly applicable, real-world resource for developing self-management behaviors to complement clinical care. Two rounds of preliminary development and feasibility trials were conducted with 105 youth with SCD, and indicated feasibility, acceptability, and a preliminary positive impact on pain interference, quality of life, and psychosocial outcomes (Phillips et al., 2020). Following adaptation informed by the feasibility trials, intervention components include: educational information; pain and symptom ecological momentary assessment (EMA) and tracking; health history information; medication tracking; functioning EMA and tracking; and sharing pain/symptom and functioning tracking graphs with the clinical team.
Design and Methods: The Self-Management for Youth Living with Sickle Cell Disease (SMYLS) study is a multisite, hybrid type I effectiveness-implementation randomized controlled trial (NIH/NINR R01NR020606; NCT06035939; Phillips et al., 2025). The trial is designed for fully remote implementation, though procedures may also be conducted in person at the participant’s preference. The 4 sites are located in the Southeastern US and have established pediatric sickle cell clinics; population sizes range from ~350 to 900. Participants include transition-aged AYA with SCD ages 14 – 25 and caregivers of adolescents, with a targeted AYA sample size of 272. Key AYA inclusion criteria are: 1) any SCD genotype, 2) owns mobile device compatible with app, 3) access to the internet, and key exclusion criteria are: 1) intent to relocate outside study site catchment in < 12 months, 2) plans to transition to adult care in < 12 months, 3) parent or provider report of prohibitive neurocognitive impairment, and 4) non-English speaking. Participants are randomized 1:1 to the intervention or enhanced usual care (eUC; a version of the app that includes only electronic educational information), stratified by age group, site, and baseline patient activation level. Assessments are conducted at baseline and 1, 3, 6, 9 (primary endpoint), and 12 months. The primary outcomes are self-management behavior (effectiveness) and engagement (implementation) with the intervention/eUC. Patient activation will be evaluated as a moderator of intervention effects on self-management behaviors. Secondary outcomes include health-related quality of life, healthcare utilization, transition readiness, and pain interference. Potential moderating variables include neurocognitive functioning, social determinants of health, and perceived discrimination, among others. Additional implementation outcomes include measures of intervention acceptability, feasibility, appropriateness, and usability. Post-intervention interviews with a subset of 35 AYA explore barriers and facilitators to implementation, guided by the Consolidated Framework for Implementation Research (CFIR) 2.0.
Primary and secondary effectiveness outcomes will be analyzed using generalized linear mixed models. Models will include fixed effects for intervention group, time, and the group-by-time interaction, and prespecified study covariates. Additional analyses will assess the moderating effects of patient activation and exploratory variables on self-management behaviors. Qualitative analysis will be conducted using directed content analysis, with the CFIR 2.0 framework.
Current Status: As of July 2026, 225 AYA have been approached, 189 enrolled, and 167 randomized across sites. Of the 189 enrolled AYA, the mean age is 16.9 years (SD 2.3), 57.4% female, 36.8% male, and 5.8% other. Racial distribution is 91.1% Black/African American, 2.1% Other/Mixed, and 6.8% prefer not to respond. Due to variability in site enrollment success, changes to study design were made including 1) adding a 4th enrolling site to the 3 from the original protocol, and 2) increasing the age range from 14 – 21 years to 14 – 25 years.
DISCLOSURES
Shannon Phillips, PhD, RN: Quilt Health - Consultancy (Includes expert testimony)